Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,457,686
-$813,743 QoQ
Shares Held
74,859
+1.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#443
of 2,266 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M. Kulyk & Associates, LLC holds $37,765,981 across 8 Drug Manufacturers - General names. GILD ranks #3 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
94,863 | $12,189,895 | |
| 2 | LLY |
ELI LILLY & Co
|
7,945 | $9,529,472 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
74,859 | $9,457,686 | |
| 4 | NVO |
Novo Nordisk A S
|
93,400 | $4,477,596 | |
| 5 | ABBV |
AbbVie Inc.
|
3,846 | $967,807 | |
| 6 | JNJ |
Johnson & Johnson
|
1,941 | $492,955 | |
| 7 | NVS |
Novartis AG
|
2,439 | $382,240 | |
| 8 | AMGN |
Amgen Inc
|
741 | $268,330 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,457,686 | 74,859 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $10,271,429 | 73,699 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $9,078,955 | 73,969 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $8,026,854 | 72,314 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,232,430 | 74,253 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,164,971 | 72,869 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,190,078 | 88,666 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,423,153 | 100,467 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $7,127,138 | 103,879 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,535,951 | 89,228 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $6,321,338 | 84,352 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $6,397,966 | 83,015 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,373,543 | 88,870 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,541,836 | 87,849 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,431,310 | 88,042 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,344,710 | 86,470 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,945,942 | 83,195 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $7,425,897 | 102,271 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $6,771,398 | 96,942 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $6,348,960 | 92,201 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $5,369,395 | 83,079 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,196,143 | 54,860 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||